fingolimod
Per policy, these hazardous drugs have special waste requirements. | |
---|---|
Generic (Brand) | Waste Requirements |
fingolimod (Gilenya) | Hazardous Waste ⇒ BLACK BUCKET |
USP <800> Hazardous Drugs | ||||||
---|---|---|---|---|---|---|
Per Policy, these drugs have special handling requirements (any drug with an "AOR" is exempt from these requirements under normal circumstances). | ||||||
generic (Brand) Route | Relative Risk Level | AOR? | NIOSH 2024 Table | MSHI?↑ | Warnings | |
fingolimod (Gilenya) PO | Medium | N/A | 2↑ | |||
NIOSH Supplemental information (2016): in laboratory studies, increased malformations and embryo fetal deaths at less than the recommended human dose; malignant lymphomas observed in male and female mice FDA Pregancy Category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks; |